Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Sana Biotechnology
Sort By
Newest First
1 / 1
1 / 1
Column: Investment
2021 Was a Great Year for Biotech IPOs, Depending on When You Got Out
Danielle Alvarez
Pharma's Almanac
PAO-03-022-NI-07
Mar 23, 2022
